1051PDIMMUNOMODULATORY ACTIVITY OF NIVOLUMAB IN PREVIOUSLY TREATED AND UNTREATED METASTATIC RENAL CELL CARCINOMA (MRCC): BIOMARKER-BASED RESULTS FROM A RANDOMIZED CLINICAL TRIAL.

Published

Journal Article

Full Text

Duke Authors

Cited Authors

  • Choueiri, T; Fishman, MN; Escudier, B; Kim, JJ; Kluger, H; Stadler, WM; Perez-Garcia, JL; McNeel, D; Curti, B; Harrison, MR; Plimack, ER; Appleman, L; Fong, L; Drake, CG; Cohen, L; Srivastava, S; Jure-Kunkel, M; Hong, Q; Kurland, J; Sznol, M

Published Date

  • September 1, 2014

Published In

Volume / Issue

  • 25 / suppl_4

Start / End Page

  • iv362 -

PubMed ID

  • 28171273

Pubmed Central ID

  • 28171273

Electronic International Standard Serial Number (EISSN)

  • 1569-8041

Digital Object Identifier (DOI)

  • 10.1093/annonc/mdu342.4

Language

  • eng

Conference Location

  • England